A surprising presentation of atypical pantothenate kinase-associated neurodegeneration disorder: metamorphopsia

被引：0
|
作者：
Elahe Amini
Zahra Azad
Reza Mirshahi
Mohammad Rohani
机构：
[1] The Five Senses Health Institute,Skull Base Research Center
[2] Rasoul Akram Hospital,Eye Research Center
[3] Iran University of Medical Sciences,Department of Neurology
[4] The Five Senses Health Institute,undefined
[5] Rasoul Akram Hospital,undefined
[6] Iran University of Medical Sciences,undefined
[7] Rasoul Akram Hospital,undefined
[8] Iran University of Medical Sciences,undefined
来源：
Neurological Sciences | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2595 / 2597
页数：2
相关论文
共 50 条
  • [21] Pantothenate Kinase-Associated Neurodegeneration - a Case Report
    Petrlenicova, D.
    Gmitterova, K.
    Uhrin, I.
    Benetin, J.
    Valkovic, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2011, 74 (02) : 201 - 204
  • [22] An atypical case of Pantothenate kinase-associated neurodegeneration presenting as late-onset parkinsonism
    Seo, J. -H.
    Kim, J. -S.
    Song, S. -K.
    Lee, P. H.
    Sohn, Y. H.
    MOVEMENT DISORDERS, 2009, 24 : S423 - S424
  • [23] Pallidal stimulation improves pantothenate kinase-associated neurodegeneration
    Castelnau, P
    Cif, L
    Valente, EM
    Vayssiere, N
    Hemm, S
    Gannau, A
    DiGiorgio, A
    Coubes, P
    ANNALS OF NEUROLOGY, 2005, 57 (05) : 738 - 741
  • [24] Metabolism and energy requirements in pantothenate kinase-associated neurodegeneration
    Williams, Sarah
    Gregory, Allison
    Hogarth, Penelope
    Hayflick, Susan J.
    Gillingham, Melanie B.
    MOLECULAR GENETICS AND METABOLISM, 2013, 110 (03) : 336 - 341
  • [25] Cannabis Use in Children With Pantothenate Kinase-Associated Neurodegeneration
    Wilson, Jenny L.
    Gregory, Allison
    Wakeman, Katrina
    Freed, Alison
    Rai, Puneet
    Roberts, Colin
    Hayflick, Susan J.
    Hogarth, Pennylope
    JOURNAL OF CHILD NEUROLOGY, 2020, 35 (04) : 259 - 264
  • [26] A Randomized Trial of Deferiprone for Pantothenate Kinase-Associated Neurodegeneration
    Klopstock, T.
    Tricta, F.
    Neumayr, L.
    Karin, I.
    Zorzi, G.
    Fradette, C.
    Kmiec, T.
    Buechner, B.
    Steele, H.
    Horvath, R.
    Chinnery, P.
    Basu, A.
    Kuepper, C.
    Neuhofer, C.
    Dusek, P.
    Zhao, F.
    Zibordi, F.
    Nardocci, N.
    Aguilar, C.
    Hayflick, S.
    Spino, M.
    Blamire, A.
    Hogarth, P.
    Vichinsky, E.
    MOVEMENT DISORDERS, 2018, 33 : S219 - S219
  • [27] Clinical heterogeneity of pantothenate kinase-associated neurodegeneration (PKAN)
    Thomas, M
    Hayflick, SJ
    Jankovic, J
    NEUROLOGY, 2002, 58 (07) : A322 - A322
  • [28] Pallidal stimulation for pantothenate kinase-associated neurodegeneration dystonia
    Isaac, C.
    Wright, I.
    Bhattacharyya, D.
    Baxter, P.
    Rowe, J.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2008, 93 (03) : 239 - 240
  • [29] Patient and Caregiver Experience With Pantothenate Kinase-Associated Neurodegeneration
    Jinnah, H.
    Lenderking, W.
    Collins, A.
    Escolar, M.
    Klopstock, T.
    Kruer, M.
    Videnovic, A.
    Robichaux-Viehoever, A.
    Swett, L.
    Revicki, D.
    Bender, R.
    Marshall, R.
    MOVEMENT DISORDERS, 2018, 33 : S228 - S228
  • [30] Amantadine for Gait Dysfunction in Pantothenate Kinase-Associated Neurodegeneration
    Al-Shorafat, Duha M.
    Lang, Anthony E.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2019, 46 (06) : 782 - 784
12345